Related Articles
Downregulation of γ-catenin inhibits CML cell growth and potentiates the response of CML cells to imatinib through β-catenin inhibition
Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib
Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia
Idelalisib induces G1 arrest and apoptosis in chronic myeloid leukemia K562 cells
EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway